《盈警響號》第一上海(00227.HK)料去年盈轉虧 蝕最少9,000萬元
第一上海(00227.HK)公布,相對集團2019年同期的溢利1,100萬元,預期集團截至去年12月31日止年度將錄得虧損不少於9,000萬元。
虧損主要由於投資物業公允值收益因此等物業的銷售或租務回報的市場前境嚴峻而減少。於去年,集團因2019冠狀病毒病全球爆發而遭遇黃山物業銷售辦事處必需關閉;無錫和巴黎酒店按政府要求突然中止營運;及於疫情期間,一般醫療服務之需求受到抑制,令使用集團於中環醫療中心的病患人數有所減少。以上的嚴重干擾,以及市場前境的挑戰,致使集團為其物業及醫療業務之約干非流動資產作出減值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.